Kirjahaku

The inside story of the race to develop Ozempic – the world’s first truly effective and safe obesity drug – and its potentially revolutionary effects on public health, and our deeper culture and values. A ‘cure’ for obesity has long been the holy grail for the pharmaceutical industry, one that seemed unattainable until recent breakthroughs in type 2 diabetes research led to the development of Ozempic, a weight loss medication that makes people feel fuller for longer. The treatment is so effective that it is already disrupting many industries – from healthcare to fast food to fashion – and it has quickly made its creator, Denmark’s Novo Nordisk, the most valuable company in Europe. But the impact of these drugs goes far beyond billion-dollar profits; a true long-term cure for obesity could significantly reduce dangerous preventable illnesses. And as their success continues to grow, one question looms in the minds of investors, healthcare workers and politicians: are they too good to be true? In Off the Scales, journalist Aimee Donnellan illuminates the history of the latest medical breakthrough that is poised to change the world, while bringing difficult social questions about inequality and morality to the forefront. Through original reporting and rigorous research, she forecasts the future of Ozempic and similar medications like Mounjaro and Wegovy, and examines what their explosive popularity tells us about our ideals of beauty, the lengths to which people will go in order to become thin, the current state of healthcare and the inner workings of the pharmaceutical industry. Along the way, Donnellan profiles the scientist whose contributions to the discovery of GLP-1 were overlooked and her fight for recognition, and offers new insights into the ways that the food and beauty industries made billions while promoting unhealthy and unrealistic body image standards and accelerating the obesity crisis. She also reveals the lengths that the celebrity class went to obtain this medication when supplies were limited and prescriptions were costly, and relates the first-hand accounts of several early Ozempic users and the transformative effect the drug has had on their weight loss journeys. Above all, Off the Scales is a gripping and informative study of the unexpected social consequences of finally getting what we've wanted for so long.

The inside story of the race to develop Ozempic - the world's first truly effective and safe obesity drug - and its potentially revolutionary effects on public health, and our deeper culture and values.

The inside story of the race to develop Ozempic, and its potentially revolutionary impact on public health and culture.A "cure" for obesity has long been the holy grail for the pharmaceutical industry, one that seemed unattainable until recent breakthroughs in type 2 diabetes research led to the development of Ozempic, a weight loss medication that activates hormones in the stomach, making people feel fuller for longer. The treatment is so effective that it is already disrupting many industries--from healthcare to fast food to fashion--and it has quickly made its creator, Denmark's Novo Nordisk, the most valuable company in Europe. But the impact of these drugs goes far beyond billion-dollar profits; a true long-term cure for obesity could save 40% of American adults from dangerous preventable illnesses. And as their success continues to grow, one question looms in the minds of investors, healthcare workers and politicians: are they too good to be true? In Off the Scales, Reuters journalist Aimee Donnellan illuminates the history of the latest medical breakthrough that is poised to change the world, while bringing difficult social questions about inequality and morality to the forefront. Through original reporting and rigorous research, she forecasts the future of Ozempic and similar medications--and examines what their explosive popularity tells us about our ideals of beauty, the lengths to which people will go in order to become thin, the current state of healthcare, and the inner workings of the pharmaceutical industry. Along the way, Donnellan profiles the scientist whose contributions to the discovery of GLP-1 were overlooked and her fight for recognition while her colleagues were thrust into the limelight, and offers new insights into the ways that the food and beauty industries made billions while promoting unhealthy and unrealistic body image standards and accelerating the obesity crisis. She also reveals the lengths that the celebrity class went to obtain this medication when supplies were limited and prescriptions were costly, and relates the first-hand accounts of several early Ozempic users and the transformative effect the drug has had on their weight loss journeys. Above all, Off the Scales is an informative and entertaining study of the unexpected social consequences of finally getting what we've wanted for so long.

"She's escaped. Gods help us all." The Theocracy of Izirm is losing a war against dragons. While the Bishops scramble for a solution, the holy city of Kequm faces a more immediate crisis: the murderous mage, Nightingale, has escaped prison and only one person can stop her. Lark is a devoted follower of the Scholar god who searches for adventure around every corner. Ever since apprehending Nightingale three years ago, they've done whatever they can to forget the hole she ripped through their heart, and can think of nothing worse than facing her again. But when Nightingale's meddling leaves Kequm vulnerable, Lark has no choice but to act.A whimsical New Adult fantasy adventure novella set in a queernormative, mysterious world begging to be explored.

"Well, you have armour. It's the lyre and the goose that have me a bit confused."The Dragon War has left its mark on everyone, and Reverie Rosetia is no exception. After her brother is struck down in a skirmish, it is on her to take up the family legacy of greatness - no matter what her plans might have been before that. She must find his sword and bring it home.With no better place to start her search, Reverie arrives at the Collection, an isolated place full of magical oddities and artifacts. Soon after her arrival, the eclectic visitors to the Collection and its owner find themselves trapped inside. A magical force has broken free and is determined to break them, one by one. Can Reverie solve the mystery of how their attacker manifested and put it right before it is too late?Reverie meets adventurers Lark and Wren as the trio are trapped in this claustrophobic and irreverent fantasy mystery, which may have more to do with Lark and Wren's chase than they think...

A cozy sapphic fantasy romance about the magic of possibility, new horizons, and fresh perspectives. At age three, Tia almost killed her mother. Born with a rare, recessive condition where her very touch inflicts deadly necrosis magic on other people, Tia has spent the last twenty years in a hidden convent in the Shilheim forest, with others sharing her affliction. Asha chases horizons. Wants to be known for doing the impossible. So when she learns of a centuries-old blood curse being hidden by the elven authorities, and her even more mysterious patron claims to know how to cure it when no one else has come close... she cannot resist. With a letter from Asha and a token from a sister she barely remembers, Tia's life is forever changed when she risks everything to escape the convent and become Asha's assistant and test subject. But the convent has always had contingency plans for escaped residents, and a single misstep could result in Tia committing manslaughter. To make matters worse, Asha can't quite keep her thoughts professional when it comes to Tia, and the phrase 'untouchable' has never been quite so accurate...

A werewolf overwhelmed by obligation. A hermit in crisis, isolated to protect her own heart. And a beast that could devour everything they hold dear. Nikos doesn't mean to run from his people. But ever since he's been brought back to life, no one has quite looked at him the same, and he just needs to breathe. When he stumbles into a skirmish and unearths a much greater threat, he leaps at the chance to run away from his responsibilities a little longer. Juniper has never felt at home in civilisation, only in the heart of the forest. But when her twin brother is taken from their isolated home, and a mysterious stranger appears and offers his help, she has little choice but to accept the additional advantage. Neither is what the other expects, and both know much more about vulnerability and fear than they want to admit. But when they learn the being behind the abductions is none other than a corrupted, magic-eating dragon, both hunters know that only a powerful alliance can bring it down. Problem is, with every moment they spend together, they risk falling into the most terrifying thing of all... intimacy. Nightwalkers of Concord returns with A Verdant Vendetta, a bisexual romantasy set one year after the epilogue of A Crimson Covenant. Can be read as a standalone.